Effectiveness of monovalent COVID-19 mRNA booster vaccination vs. two-dose primary series during Omicron variant circulation

3D render of a medical background with DNA strands

Researchers estimated the immune protection conferred by monovalent-type COVID-19 mRNA booster doses vs. two-dose prime vaccination series during SARS-CoV-2 Omicron variant predominance in community settings.

Prescribing of key heart failure medications improved with tailored digital alerts

Previous article

How ChatGPT could be changing poker

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News